Company profile: CinCor Pharma
1.1 - Company Overview
Company description
- Provider of clinical-stage biopharmaceutical research and development focused on cardiovascular, metabolic, and kidney diseases, advancing promising clinical candidates toward marketing approval, including CIN-107, a novel aldosterone synthase inhibitor.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to CinCor Pharma
U.S. Stem Cell
HQ: United States
Website
- Description: Provider of regenerative medicine and autologous cellular therapies for degenerative conditions, offering in-clinic solutions and training for physicians, regenerative medicine solutions for veterinary patients, and collaboration with industry innovators on R&D of cell-based therapeutics aimed at repairing damaged tissue.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full U.S. Stem Cell company profile →
TriVascular
HQ: United States
Website
- Description: Provider of new medical devices delivering optimal solutions for endovascular aortic repair (EVAR).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TriVascular company profile →
Hoana Medical
HQ: United States
Website
- Description: Provider of intelligent medical vigilance systems for healthcare.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hoana Medical company profile →
Millipede Medical
HQ: United States
Website
- Description: Provider of a percutaneous, catheter-based solution for mitral valve repair and treatment of mitral and tricuspid regurgitation, restoring health and expanding options for physicians and patients globally.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Millipede Medical company profile →
Coherex Medical
HQ: United States
Website
- Description: Provider of medical devices addressing structural heart disease, including a patent foramen ovale (PFO) closure system designed to stimulate tissue in-growth for long-term closure, and the WaveCrest Left Atrial Appendage Occlusion System to close the left atrial appendage and reduce stroke risk in atrial fibrillation patients who cannot tolerate chronic oral anticoagulation therapy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Coherex Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for CinCor Pharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to CinCor Pharma
2.2 - Growth funds investing in similar companies to CinCor Pharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for CinCor Pharma
4.2 - Public trading comparable groups for CinCor Pharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →